Semax
$60.00
Semax Peptide is a research-grade peptide intended for laboratory and scientific research involving neuropeptide signaling, cellular communication, neurological pathways, and molecular mechanisms. It is designed for controlled experimental studies investigating peptide activity and cellular responses.
Semax may be investigated in laboratory settings involving neural signaling pathways, peptide-receptor interactions, cellular communication, oxidative-stress mechanisms, and molecular responses. It is suitable for researchers conducting controlled peptide, cellular, and neuroscience-related research.
Manufactured using high-purity research ingredients, VIDA Semax is intended exclusively for research and laboratory applications. This product is not intended for human or veterinary use.
Key Features
- Advanced Semax Research Peptide Formula
- High-Purity Research Peptide
- Suitable for Controlled Laboratory Research
- Supports Research into Neuropeptide Signaling
- Investigated for Neural and Cellular Pathways
- Suitable for Molecular and Neuroscience Studies
- Ideal for Scientific and Experimental Research
- Research Use Only – Not for Human or Veterinary Use
| Size | 10MG |
|---|
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
Reviews
There are no reviews yet.